Religare Health Trust

Download the Prospectus here

Religare Health Trust 




Offer Price: $0.90
Offer Size: 567m new shares 

Public Tranche – 12m shares
Placement Tranche – about 555m shares
Market Cap (post-IPO): S$709m
Open: 15 October 2012
Close: 18 October 2012, 12.00 noon
Trading: 22 October 2012, 9.00 a.m. (on “ready” basis) 

Introducation

Religare Health Trust (Religare or RHT) is the first business trust
with an initial portfolio comprising healthcare assets in India to be
listed on the Main Board of the SGX-ST. RHT’s investment mandate
is principally to invest in medical and healthcare assets and services
in Asia, Australasia and emerging markets in the rest of the world.
RHT may also develop medical and healthcare assets. It is expected
that the medical services will be provided directly by RHT
or in collaboration with third parties.

RHT’s initial portfolio comprises 11 clinical establishments, four clinical
establishments and two operating hospitals located across India , with
an aggregate value of `32,577 million (S$748.0 million), based on the
valuation by the Independent Valuer.




Projected distribution Yield





Investment Highlights





Use of IPO Proceeds 




Financial Highlights





Personal View

For the readers who have been reading my Stock Lobang
blog and this IPO blog, you should know that I like the
medical sector and the stocks that is in the sector too.
Religare allows the investor to have the exposure to the
growing Indian Healthcare Sector which is growing due to
the large and ever-increasing population and changing
demographic. Looking at the performance of its recent listed
peer, IHH Healthcare, I expect a strong debut of the stock
next Monday. With 12 million share set aside for public
application, I believe that there is enough supply for the
hungry investors, and that means me as well. I will gladly
SUBSCRIBE for the IPO,and hope to add to my increasing
medical stock portfolio holding with this rewarding gem.